Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1043]

Biosimilars set to change European oncology landscape

Biosimilars set to change European oncology landscape

Reduction in cardiac events for prostate cancer patients with pre-existing cardiovascular disease with degarelix compared to LHRH agonists

Reduction in cardiac events for prostate cancer patients with pre-existing cardiovascular disease with degarelix...

Kinase drug targets for prostate cancer are heterogeneous between patients but homogeneous within the same patient

Kinase drug targets for prostate cancer are heterogeneous between patients but homogeneous within the same patient

SABCS 2013: New combination therapy fails to delay progression of advanced breast cancer

SABCS 2013: New combination therapy fails to delay progression of advanced breast cancer

SABCS 2013: PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant

SABCS 2013: PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant

SABCS 2013: Antihormone therapy anastrozole may provide new option for breast cancer prevention

SABCS 2013: Antihormone therapy anastrozole may provide new option for breast cancer prevention

Anastrozole cuts breast cancer cases by more than 50% in high risk women

Anastrozole cuts breast cancer cases by more than 50% in high risk women

Measuring segments of genetic material may help predict and monitor recurrence after thyroid cancer surgery

Measuring segments of genetic material may help predict and monitor recurrence after thyroid cancer surgery

ASTRO 2013: Long-term hormonal therapy in intermediate-risk prostate cancer patients does not improve overall survival

ASTRO 2013: Long-term hormonal therapy in intermediate-risk prostate cancer patients does not improve overall...

ASTRO 2013: Fewer weeks of hormone therapy before radiation treatment reduces side effects and yields comparable disease-specific-survival for prostate cancer patients

ASTRO 2013: Fewer weeks of hormone therapy before radiation treatment reduces side effects and yields comparable...

More from ecancer